1. Home
  2. CYTH
  3. CYTH News

Latest Cyclo Therapeutics Inc. (CYTH) News on December 23, 2024

Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results
CYTH

GlobeNewswire

12 days ago

Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results

CYTH

Business Wire

a month ago

Cyclo Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
CYTH

GlobeNewswire

2 months ago

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results

Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer
CYTH

GlobeNewswire

2 months ago

Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer

CYTH

Business Wire

4 months ago

Cyclo Therapeutics Presents Encouraging Preliminary Safety Data from Ongoing Pivotal Phase 3 Study and Substudy for the Treatment of Niemann-Pick Disease Type C1 (NPC1)

Rafael Holdings and Cyclo Therapeutics Enter into a Definitive Merger Agreement
CYTH

GlobeNewswire

4 months ago

Rafael Holdings and Cyclo Therapeutics Enter into a Definitive Merger Agreement

Cyclo Therapeutics Second Quarter 2024 Earnings: Misses Expectations
CYTH

Simply Wall St.

4 months ago

Cyclo Therapeutics Second Quarter 2024 Earnings: Misses Expectations

CYTH

Business Wire

4 months ago

Cyclo Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

CYTH

Business Wire

5 months ago

Cyclo Therapeutics Announces Notice of Decision to Grant European Patent Application for Treatment of Alzheimer’s Disease from European Patent Office

CYTH

Business Wire

6 months ago

Cyclo Therapeutics to Present at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2024

Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results
CYTH

GlobeNewswire

6 months ago

Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results

CYTH

Business Wire

7 months ago

Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1

CYTH

Business Wire

7 months ago

Cyclo Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Pleasing Signs As A Number Of Insiders Buy Cyclo Therapeutics Stock
CYTH

Simply Wall St.

8 months ago

Pleasing Signs As A Number Of Insiders Buy Cyclo Therapeutics Stock

CYTH

Business Wire

9 months ago

Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

CYTH

Business Wire

9 months ago

Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer’s Disease

Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results
CYTH

GlobeNewswire

9 months ago

Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results

Advanced Emissions Solutions Completes Rebrand as Arq and Will Ring NASDAQ Opening Bell on February 1, 2024
CYTH

GlobeNewswire

a year ago

Advanced Emissions Solutions Completes Rebrand as Arq and Will Ring NASDAQ Opening Bell on February 1, 2024

Caledonia Mining Corporation Plc: Encouraging results from deep level drilling at Blanket Mine
CYTH

GlobeNewswire

a year ago

Caledonia Mining Corporation Plc: Encouraging results from deep level drilling at Blanket Mine

CYTH

Business Wire

a year ago

Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office

CYTH

Associated Press Finance

a year ago

Ohio Valley Banc: Q4 Earnings Snapshot

Ohio Valley Banc Corp. Reports 4th Quarter and Fiscal Year Earnings
CYTH

PR Newswire

a year ago

Ohio Valley Banc Corp. Reports 4th Quarter and Fiscal Year Earnings

Zentek Completes Study Quantifying Energy and Emission Savings of ZenGUARD(TM)-Enhanced HVAC Filters
CYTH

ACCESSWIRE

a year ago

Zentek Completes Study Quantifying Energy and Emission Savings of ZenGUARD(TM)-Enhanced HVAC Filters

CYTH

Business Wire

a year ago

Tillys Announces Leadership Transition

Freshpet, Tilly’s, and More Stocks See Action From Activist Investors
CYTH

Barrons.com

a year ago

Freshpet, Tilly’s, and More Stocks See Action From Activist Investors

Grove Collaborative Appoints Scott Giesler as General Counsel
CYTH

Business Wire

a year ago

Grove Collaborative Appoints Scott Giesler as General Counsel

Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01
CYTH

GlobeNewswire

a year ago

Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01

Canoo Delivered Electric Vehicles to Kingbee
CYTH

GlobeNewswire

a year ago

Canoo Delivered Electric Vehicles to Kingbee

Wall Street Analysts Predict a 199.31% Upside in Syros Pharmaceuticals, Inc. (SYRS): Here's What You Should Know
CYTH

Zacks

a year ago

Wall Street Analysts Predict a 199.31% Upside in Syros Pharmaceuticals, Inc. (SYRS): Here's What You Should Know

Abeona Therapeutics Inc. (NASDAQ:ABEO): When Will It Breakeven?
CYTH

Simply Wall St.

a year ago

Abeona Therapeutics Inc. (NASDAQ:ABEO): When Will It Breakeven?

CYTH

Associated Press Finance

a year ago

Pure Cycle: Fiscal Q1 Earnings Snapshot

Pure Cycle Announces Financial Results For the Three Months Ended November 30, 2023
CYTH

ACCESSWIRE

a year ago

Pure Cycle Announces Financial Results For the Three Months Ended November 30, 2023

abrdn U.S. Closed End Funds Announce Distribution Payment Details
CYTH

ACCESSWIRE

a year ago

abrdn U.S. Closed End Funds Announce Distribution Payment Details

The 3 Best EV Charging Stocks to Buy in January 2024
CYTH

InvestorPlace

a year ago

The 3 Best EV Charging Stocks to Buy in January 2024

CorMedix Inc. Announces Commercial and Operational Updates
CYTH

GlobeNewswire

a year ago

CorMedix Inc. Announces Commercial and Operational Updates

Clough Global Dividend and Income Fund Declares Monthly Cash Distributions for January, February, and March 2024 of $0.0526 Per Share
CYTH

ACCESSWIRE

a year ago

Clough Global Dividend and Income Fund Declares Monthly Cash Distributions for January, February, and March 2024 of $0.0526 Per Share

Werewolf Therapeutics Appoints Michael Atkins, M.D., to its Board of Directors
CYTH

GlobeNewswire

a year ago

Werewolf Therapeutics Appoints Michael Atkins, M.D., to its Board of Directors

P3 Health Partners to Present at the 42nd Annual J.P. Morgan Healthcare Conference
CYTH

Business Wire

a year ago

P3 Health Partners to Present at the 42nd Annual J.P. Morgan Healthcare Conference

CYTH

Business Wire

a year ago

Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.

ACRES Commercial Realty Corp. Declares Quarterly Cash Dividends for its Preferred Stock
CYTH

PR Newswire

a year ago

ACRES Commercial Realty Corp. Declares Quarterly Cash Dividends for its Preferred Stock

First Community Corporation Announces 2024 Earnings Release Schedule
CYTH

PR Newswire

a year ago

First Community Corporation Announces 2024 Earnings Release Schedule

Anavex (AVXL) Rises as CHMP Deems Blarcamesine Eligible for MAA
CYTH

Zacks

a year ago

Anavex (AVXL) Rises as CHMP Deems Blarcamesine Eligible for MAA

BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient Subset
CYTH

GlobeNewswire

a year ago

BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient Subset

a.k.a. Brands Holding Corp. Announces Increase to Share Repurchase Program
CYTH

Business Wire

a year ago

a.k.a. Brands Holding Corp. Announces Increase to Share Repurchase Program

CYTH

Business Wire

a year ago

Cyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1

Life Science Investor Forum: Presentations Now Available for Online Viewing
CYTH

GlobeNewswire

a year ago

Life Science Investor Forum: Presentations Now Available for Online Viewing

Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results
CYTH

GlobeNewswire

a year ago

Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results

Neurohacker Collective and ChromaDex Partner to Optimize Cellular Health with the Debut of Qualia NAD+
CYTH

PR Newswire

a year ago

Neurohacker Collective and ChromaDex Partner to Optimize Cellular Health with the Debut of Qualia NAD+

Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy Bodies
CYTH

GlobeNewswire

a year ago

Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy Bodies

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
CYTH

GlobeNewswire

a year ago

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

Here's Why We're A Bit Worried About Carisma Therapeutics' (NASDAQ:CARM) Cash Burn Situation
CYTH

Simply Wall St.

a year ago

Here's Why We're A Bit Worried About Carisma Therapeutics' (NASDAQ:CARM) Cash Burn Situation

SecureWorks Corp (SCWX) Reports Q3 Fiscal 2024 Earnings: Taegis Drives Growth Amidst Strategic Shift
CYTH

GuruFocus.com

a year ago

SecureWorks Corp (SCWX) Reports Q3 Fiscal 2024 Earnings: Taegis Drives Growth Amidst Strategic Shift

ARC Announces Quarterly Dividend
CYTH

ACCESSWIRE

a year ago

ARC Announces Quarterly Dividend

Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCS
CYTH

CNW Group

a year ago

Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCS

System1 to Participate in The Benchmark Company’s Discovery One-on-One Investor Conference
CYTH

Business Wire

a year ago

System1 to Participate in The Benchmark Company’s Discovery One-on-One Investor Conference

Natuzzi S.p.A. (NYSE:NTZ) Q3 2023 Earnings Call Transcript
CYTH

Insider Monkey

a year ago

Natuzzi S.p.A. (NYSE:NTZ) Q3 2023 Earnings Call Transcript

FinWise Bancorp (FINW) Is a Great Choice for 'Trend' Investors, Here's Why
CYTH

Zacks

a year ago

FinWise Bancorp (FINW) Is a Great Choice for 'Trend' Investors, Here's Why

Niu Technologies (NASDAQ:NIU) Q3 2023 Earnings Call Transcript
CYTH

Insider Monkey

a year ago

Niu Technologies (NASDAQ:NIU) Q3 2023 Earnings Call Transcript

CYTH

Business Wire

a year ago

Cyclo Therapeutics to Present at the 20th Annual WORLDSymposium™ 2024

Institutions profited after Gossamer Bio, Inc.'s (NASDAQ:GOSS) market cap rose US$59m last week but individual investors profited the most
CYTH

Simply Wall St.

a year ago

Institutions profited after Gossamer Bio, Inc.'s (NASDAQ:GOSS) market cap rose US$59m last week but individual investors profited the most

CYTH

Business Wire

a year ago

Cyclo Therapeutics Reports Third Quarter 2023 Financial Results

CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2023 BUSINESS AND FINANCIAL UPDATES
CYTH

PR Newswire

a year ago

CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2023 BUSINESS AND FINANCIAL UPDATES

Wrap Technologies, Inc. Reports Third Quarter 2023 Results and Record Quarterly Revenue
CYTH

GlobeNewswire

a year ago

Wrap Technologies, Inc. Reports Third Quarter 2023 Results and Record Quarterly Revenue

Hyliion Holdings Reports Third-Quarter 2023 Financial Results
CYTH

Business Wire

a year ago

Hyliion Holdings Reports Third-Quarter 2023 Financial Results

Viatris (VTRS) Beats Q3 Earnings Estimates
CYTH

Zacks

a year ago

Viatris (VTRS) Beats Q3 Earnings Estimates

Vistagen to Present Positive Fasedienol Phase 3 Data and Positive PH80 Phase 2A Data at Upcoming Scientific Conferences
CYTH

Business Wire

a year ago

Vistagen to Present Positive Fasedienol Phase 3 Data and Positive PH80 Phase 2A Data at Upcoming Scientific Conferences

Share on Social Networks: